Neuropharmacology and CNS Drug Research

Neuropharmacology explores the effects of drugs on the central and peripheral nervous systems, addressing neurological and psychiatric disorders such as Alzheimer’s disease, Parkinson’s disease, depression, and epilepsy. Advancements in CNS drug research focus on molecular mechanisms, neurotransmitter modulation, receptor targeting, and synaptic plasticity. Novel small molecules, biologics, and gene therapies are being developed to cross the blood-brain barrier effectively. Preclinical models, neuroimaging, and electrophysiology studies provide insights into efficacy, safety, and neurotoxicity. Precision approaches integrating genomics and biomarkers facilitate patient-specific therapies, improving outcomes for complex neurodegenerative and psychiatric conditions.

    Related Conference of Neuropharmacology and CNS Drug Research

    January 22-23, 2026

    26th World Congress on Medicinal Chemistry and Drug Design

    Bangkok, Thailand
    February 25-26, 2026

    16th International Conference on Chemistry Meeting

    Paris, France
    February 26-27, 2026

    29th World Congress on Materials Chemistry

    Paris, France
    June 17-18, 2026

    15th World Congress on Chromatography

    Paris, France
    August 11-12, 2026

    5th World Congress on Plasma Chemistry and Plasma Processing

    Amsterdam, Netherlands
    September 21-22, 2026

    16th International Chemistry Congress

    Barcelona, Spain
    November 26-27, 2026

    6th International Conference on Petrochemistry and Natural Gas

    Amsterdam, Netherlands

    Neuropharmacology and CNS Drug Research Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in